Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

Safety and immunogenicity of a paediatric presentation of an influenza vaccine.

Gonzalez M, Pirez MC, Ward E, Dibarboure H, García A, Picolet H.

Arch Dis Child. 2000 Dec;83(6):488-91.

2.

Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.

Mitchell DK, Ruben FL, Gravenstein S.

Pediatr Infect Dis J. 2005 Oct;24(10):925-7.

PMID:
16220095
3.

[Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].

Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Jul;24(7):570-3. Chinese.

PMID:
12975010
4.

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

Squarcione S, Sgricia S, Biasio LR, Perinetti E.

Vaccine. 2003 Mar 7;21(11-12):1268-74.

PMID:
12559808
5.

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.

Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A.

Pediatr Infect Dis J. 2009 Jul;28(7):563-71. doi: 10.1097/INF.0b013e31819d6394.

PMID:
19561422
6.

Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.

Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.

Medicina (B Aires). 2007;67(4):351-9.

PMID:
17891930
7.

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.

Neuzil KM, Dupont WD, Wright PF, Edwards KM.

Pediatr Infect Dis J. 2001 Aug;20(8):733-40.

PMID:
11734733
8.

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.

Zangwill KM, Droge J, Mendelman P, Marcy SM, Partridge S, Chiu CY, Jing J, Chang SJ, Cho I, Ward JI.

Pediatr Infect Dis J. 2001 Aug;20(8):740-6.

PMID:
11734734
9.

[Safety and immunogenicity of split vaccines of influenza viruses].

Zhu CL, Fang HH, Zhu FC, Wang YQ, Wu XL, Xue FB, Shen YJ, Lian JZ.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Sep;18(3):207-9. Chinese.

PMID:
15640848
10.

Influenza vaccine in healthy preschool children.

Colombo C, Argiolas L, La Vecchia C, Negri E, Meloni G, Meloni T.

Rev Epidemiol Sante Publique. 2001 Apr;49(2):157-62.

PMID:
11319482
11.

[Safety of an influenza-split-vaccine in children].

Schmitt-Grohé S, Banzhoff A, Klaassen B, Zielen S.

Klin Padiatr. 2001 Nov-Dec;213(6):338-42. German.

PMID:
11713714
12.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
13.

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors.

Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, Newman FK, Yu O, Weniger BG; Vaccine Safety Datalink Study Group..

Vaccine. 2001 Sep 14;19(32):4703-9.

PMID:
11535320
14.

Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial.

Oh CE, Lee J, Kang JH, Hong YJ, Kim YK, Cheong HJ, Ahn YJ, Kim SH, Lee HJ.

Vaccine. 2010 Aug 16;28(36):5857-63. doi: 10.1016/j.vaccine.2010.06.060.

PMID:
20600483
15.

Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.

Van Hoecke C, Prikazsky V, Utö I, Menschikowski C.

Gerontology. 1996;42(4):190-8.

PMID:
8832266
16.

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.

Lu CY, Shao PL, Chang LY, Huang YC, Chiu CH, Hsieh YC, Lin TY, Huang LM.

Vaccine. 2010 Aug 16;28(36):5864-70. doi: 10.1016/j.vaccine.2010.06.059.

PMID:
20600484
17.

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, Stoney T, McVernon J, Hartel G, Sawlwin DC, Bennet J, Ryan D, Basser RL, Zambon MC.

Vaccine. 2008 Nov 25;26(50):6383-91. doi: 10.1016/j.vaccine.2008.08.046.

PMID:
18801398
19.

Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.

Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC28 Study Team..

Pediatr Infect Dis J. 2010 Feb;29(2):105-10. doi: 10.1097/INF.0b013e3181b84c34.

PMID:
19934787
20.

Dose sparing with intradermal injection of influenza vaccine.

Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM.

N Engl J Med. 2004 Nov 25;351(22):2295-301.

Supplemental Content

Support Center